Table 5 Hemostatic parameters during ECCO2R therapy
From: Daily use of extracorporeal CO2 removal in a critical care unit: indications and results
Devices | Duration of therapy (days) | Platelets count (G/L) | Anti-Xa activity (UI/mL) | Hemolysis | RBC transfusion during ECCO2R | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J0 | J1 | J2 | J3 | J4 | J5 | J0 | J1 | J2 | J3 | J4 | J5 | ||||
All patients (n = 33) | 7 [5–10] | 202 [137–286] | 167 [95–243] | 143 [88–199] | 130 [79–192] | 128 [89–156] | 124 [86–153] | 0.22 [0.14–0.47] | 0.26 [0.16–0.40] | 0.33 [0.24–0.44] | 0.33 [0.25–0.41] | 0.30 [0.20–0.39] | 0.35 [0.21–0.47] | 16 (48) | 16 (48) |
Hemolung® (n = 17) | 7 [5–10] | 210 [163–264] | 184 [108–243] | 136 [88–208] | 121 [79–174] | 128 [89–153] | 130 [88–151] | 0.24 [0.15–0.50] | 0.26 [0.20–0.36] | 0.41 [0.30–0.53] | 0.31 [0.25–0.42] | 0.30 [0.20–0.38] | 0.35 [0.30–0.49] | 13 (76) | 9 (53) |
Prismalung® (n = 10) | 5 [3–6] | 153 [104–272] | 126 [65–241] | 124 [72–195] | 105 [57–183] | 82 [57–98] | 77 [55–87] | 0.13 [0.10–0.43] | 0.17 [0.10–0.24] | 0.25 [0.10–0.41] | 0.37 [0.14–0.40] | 0.23 [0.12–0.35] | 0.20 [0.11–0.36] | 1 (10) | 4 (40) |
ILA® (n = 4) | 10 (5–19)* | 226 [150–288] | 181 [155–225] | 172 [142–206] | 186 [167–208] | 151 [134–184] | 173 [146–199] | 0.19 [0.16–0.28] | 0.36 [0.29–0.39] | 0.26 [0.25–0.29] | 0.37 [0.32–0.42] | 0.31 [0.24–0.34] | 0.26 [0.22–0.31] | 1 (25) | 3 (75) |
Maquet® (n = 2) | 6.5 (6–7)* | 258 [205–311] | 179 [163–195] | 151 [141–162] | 142 [130–153] | 142 [130–153] | 153 [153–153] | 0.27 [0.25–0.30] | 0.49 [0.44–0.53] | 0.47 [0.46–0.47] | 0.45 [0.42–0.47] | 0.58 [0.55–0.61] | 0.47 [0.46–0.47] | 1 (50) | 0 (0) |